| # | Drug | Count |
|---|---|---|
| 0 | PEMBROLIZUMAB | 9 |
| 1 | METOPROLOL | 8 |
| 2 | METOPROLOL TARTRATE | 8 |
| 3 | OMEPRAZOLE MAGNESIUM | 8 |
| 4 | CARBOPLATIN | 7 |
| 5 | METHYLPREDNISOLONE | 7 |
| 6 | OMEPRAZOLE | 7 |
| 7 | TUCATINIB | 7 |
| 8 | BOSENTAN | 6 |
| 9 | METOPROLOL TARTRATE INJECTION | 6 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | MEXILETINE HYDROCHLORIDE | 1 | 0.0024 |
| 1 | PENTOXIFYLLINE | 6 | 0.0014 |
| 2 | DOCUSATE SODIUM 50 MG SENNOSIDES 8.6 MG | 1 | 0.0013 |
| 3 | SENNOSIDES 8.6MG AND DOCUSATE SODIUM 50MG | 1 | 0.0013 |
| 4 | DOCUSATE SODIUM 50MG AND SENNOSIDES 8.6MG | 1 | 0.0011 |
| 5 | STANDARDIZED SENNA CONCENTRATE AND DOCUSATE SODIUM | 1 | 0.0007 |
| 6 | LIDOCAINE HCL | 1 | 0.0004 |
| 7 | SENNOSIDES AND DOCUSATE SODIUM | 1 | 0.0003 |
| 8 | CAPIVASERTIB | 1 | 0.0003 |
| 9 | INFLIXIMAB-DYYB | 1 | 0.0003 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Blood Viscosity Reducer [EPC] | 6 | 0.0014 |
| 1 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 2 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 11 | 0.0001 |
| 3 | HER2/neu Receptor Antagonist [EPC] | 5 | 0.0001 |
| 4 | Provitamin D2 Compound [EPC] | 1 | 0.0000 |
| 5 | Kinase Inhibitor [EPC] | 17 | 0.0000 |
| 6 | Topoisomerase Inhibitor [EPC] | 2 | 0.0000 |
| 7 | Platinum-based Drug [EPC] | 7 | 0.0000 |
| 8 | Estrogen Receptor Antagonist [EPC] | 1 | 0.0000 |
| 9 | Serotonin-3 Receptor Antagonist [EPC] | 3 | 0.0000 |